Bausch Health Companies Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Shareholders held by Bausch Health Companies Inc. on May 19, 2026. The filing details the outcomes of three shareholder proposals regarding board elections, executive compensation, and auditor appointment.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholders voted on three key proposals with the following outcomes:
- Proposal 1: Election of Directors. All 10 nominees were elected to the Board of Directors, including new director Eiry W. Roberts, M.D. Votes ranged from approximately 183.9 million "For" (Frank D. Lee) to 196.9 million "For" (Eiry W. Roberts, M.D.).
- Proposal 2: Advisory Vote on Executive Compensation. The proposal was approved with 189,432,400 votes "For" versus 9,588,417 votes "Against".
- Proposal 3: Appointment of Auditors. PricewaterhouseCoopers LLP was appointed as the independent registered public accounting firm with 276,774,936 votes "For".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the voting results of the Annual Meeting.
Investor Verification Checklist
- Verify the tenure of the newly elected director, Eiry W. Roberts, M.D., which extends until the 2027 Annual Meeting.
- Confirm the appointment of PricewaterhouseCoopers LLP as the auditor for the fiscal year ending in 2027.
- Review the Management Proxy Circular for detailed breakdowns of the "Broker Non-Votes" which totaled approximately 79.8 million across all proposals.